Meanwhile, we also summarized the candidates for treating diverse diseases involved in JAK/STAT signaling, such as anti-cancer, ameliorating inflammation, allergic asthma, chronic kidney disease, rheumatoid arthritis, and fibrosis. This evidence concerns the gene SOAT1 and cancer.